|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's range||45.11 - 46.98|
|52-week range||44.50 - 61.06|
|Beta (5Y monthly)||0.67|
|PE ratio (TTM)||30.81|
|Forward dividend & yield||1.03 (2.26%)|
|Ex-dividend date||10 May 2021|
|1y target est||N/A|
PHG earnings call for the period ending June 30, 2021.
(Reuters) -Dutch health technology company Philips announced forecast-beating earnings and a share buyback on Monday but failed to allay investor concerns over the rising cost of a recall of its respiratory devices. Philips is working to repair and replace up to 4 million respiratory devices and ventilators it recalled in June due to a foam part that might degrade and become toxic, potentially causing cancer. Though Philips has booked 500 million euros in provisions over the last two quarters as it looks to repair and replace the devices, this does not cover the possible costs of litigation from a number of class action lawsuits.